Rapport Therapeutics (RAPP): Director bought ~$32K

~$32K

Approx. value · 1,172 sh @ $26.92

9,411

Holds after · shares reported

Traded

Oct 22, 2026

Filed

Oct 22, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 23, 2026Insider · 1 personInsiders: 3 sales (~$87K)
2. Sep 30, 2026Insider · 1 personInsiders: 2 sales (~$332K)
3. Oct 6, 2026InsiderCEO sold ~$108K of RAPP shares in the open market
4. Oct 7, 2026InsiderCEO sold ~$35K of RAPP shares in the open market
5. Oct 21, 2026Insider · 2 peopleInsiders: 1 purchase (~$144K), 1 sale (~$64K)
6. Oct 22, 2026 · this disclosureInsider · 6 days before resultsDirector purchased ~$32K of RAPP shares in the open market

What came next

1. Oct 22, 2026Insider · 4 peopleInsiders: 4 purchases (~$1.4M)
2. Oct 23, 2026Insider · 5 days before resultsDirector purchased ~$98K of RAPP shares in the open market
3. Oct 28, 2026Company filing · Form 8-K · Material agreement, ResultsSigned an important agreement, and reported its results (and 2 more items)
4. Oct 28, 2026Insider · 1 personInsiders: 4 purchases (~$20.4M)
5. Nov 4, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Rapport Therapeutics

For Rapport Therapeutics, OQRO holds 20 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RAPP page.

Other recent filings by John Maraganore, Director

• SEC Form 4 at Rapport Therapeutics (RAPP)Oct 22, 2026

The full history of John Maraganore, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Rapport Therapeutics

• SEC Form 4Oct 30, 2026
• SEC Form 4Oct 30, 2026
• SEC Form 4Oct 30, 2026
• SEC Form 4Oct 30, 2026
• SEC Form 4Oct 23, 2026
• SEC Form 4Oct 23, 2026

Everything OQRO holds on this company is on its RAPP page.